UNCONTROLLED EPILEPSY
Did you know? For nearly 30 years,
the rate of seizure freedom has remained the same, even with new antiseizure medications (ASMs) coming to market1,2*


RATES OF ZERO SEIZURES BY DECADE OF APPROVAL FOR A RANGE OF ASMs3†
1990-19994,5
2.1%-8.7%
2000-20096,7
2.2%-7.4%
2010-20198-10
2.0%-8.2%
Epilepsy is not as controlled as you may think
HEAR FROM DR SELIM R. BENBADIS, MD ON THE DANGERS OF UNCONTROLLED EPILEPSY
Why seizure freedom
must remain the goal
In this video, Dr Benbadis, MD discusses why despite one-third of epilepsy patients remaining drug-resistant, his goal is always to aim for seizure freedom, and thus, the importance of trying different treatment options with these patients.
Prior to the 1990s, there was little information on seizure
freedom rates with ASMs used as add-on therapy—and even
less information about how these rates were determined3
About 60% of people with epilepsy have partial-onset seizures—
many adults with epilepsy continue to have seizures1,11-13
*Active epilepsy was defined as having self-reported doctor-diagnosed epilepsy,
either under treatment or with seizure activity in the past 12 months.11
REDEFINING TREATMENT OPTIONS
Just one seizure can make
an impact on patients’ lives


WHEN PATIENTS CONTINUE TO HAVE SEIZURES, THEY ARE1*:
6X
more likely to
have depression
4.5X
more likely to be
prevented from driving
3X
more likely to have
poor health and to experience limitations in employment and life
2X
more likely to have limits in education
Patients with uncontrolled seizures have an increased risk of SUDEP2†
HEAR FROM DR SELIM R. BENBADIS, MD ON THE NEED FOR THE SUDEP CONVERSATION
The risk of complacency:
Talking to patients about SUDEP
In this video, hear Dr Benbadis, MD speak to the importance of fighting complacency in drug-resistant patients, and why discussing the risk of SUDEP with patients who continue to face uncontrolled seizures can be a critical conversation to have.
Discover
once-daily XCOPRI1

PM-US-XCOP-0862